10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Archives : Old artciles

Tuesday, January 31, 2012

Colgate-Palmolive (India) Ltd:-Buy/sell/growth prospects and recommendation,news and results,target and analysis,view and outlook,multibagger

Scripscan:Colgate-Palmolive (India) Ltd

Story:Colgate Palmolive (CLGT) posted 74% YoY growth in 3QFY12 PAT to INR1.16b v/s estimate of INR1.01b. Toothpaste volume growth was robust at 15%. Market share during the period December 2010-November 2011 was 52.5%. Overall volume growth was 13% for the second consecutive quarter. EBITDA margin expanded 550bp YoY as OHM (Oral Health Month) got pushed from 3Q to 4Q, resulting in 550bp decline in ad spend. 520bp lower tax rate also boosted profitability.CLGT is setting up a new toothpaste facility at Sanand in Gujarat, for which it has paid lease charges of INR426m for land.I estimate the capital cost at INR2b spread over FY12 and FY13. The company has sufficient capacity to maintain its growth trajectory till the new unit comes on stream. Competitive intensity in oral care is a major challenge for CLGT in the medium term;I note that it has been losing toothbrush market share to P&G's Oral-B in recent months. CLGT is also facing intense competition from Glaxo's Sensodyne in the super premium segment. Media reports indicate that P&G has started pilot testing of toothpaste in India, which could result in its product being launched in FY13 itself.I expect sales growth and profit margins to take a hit once P&G launches its toothpaste in India.Am raising earnings estimates by 1%, which captures the net impact of lower interest income due to capex and tax rate 100-150bp lower than the earlier estimate.I expect 12.5% PAT CAGR over FY11-13, led largely by volume growth in oral care. The stock trades at 31x FY12E and 26x FY13E EPS. Current valuations build in structural positives and are at 25% premium to the 5-year average P/E multiple. Maintain Sell with a target of 900rs.

Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner